Related Experiment Video
Updated: Nov 16, 2025

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
Published on: October 16, 2021
Recurrent pericarditis: an update on diagnosis and management
Alessandro Andreis1, Massimo Imazio2, Matteo Casula1
1Division of Cardiology, Department of Medical Sciences, Città Della Salute E Della Scienza Di Torino Hospital, University of Torino, Corso Bramante 88, 10141, Torino, Italy.
Recurrent pericarditis poses a clinical challenge, especially with treatment resistance. This review covers diagnosis and novel therapies, including anti-interleukin-1 agents for refractory cases.
Area of Science:
- Cardiology
- Immunology
- Inflammatory Diseases
Background:
- Recurrent pericarditis presents significant clinical challenges, particularly in patients unresponsive or intolerant to standard treatments.
- Accurate diagnosis, potentially aided by advanced imaging, is crucial for effective symptom management and preventing future episodes.
- Emerging research into cardiovascular inflammatory pathways has prompted investigation into targeted therapies.
Purpose of the Study:
- To review the diagnostic approaches for recurrent pericarditis.
- To discuss the latest therapeutic advancements for recurrent pericarditis.
- To highlight the role of anti-interleukin-1 agents in managing refractory cases.
Main Methods:
- Comprehensive literature search of major bibliographic databases (MEDLINE/PubMed, Scopus, EMBASE, etc.).
- Keywords used included "recurrent pericarditis", "diagnosis", "treatment", "IL-1", and "inflammation".
- Focus on diagnostic assessment and modern therapeutic strategies.
Main Results:
- The review synthesizes current knowledge on diagnosing recurrent pericarditis.
- It explores recent therapeutic advances, including the use of anti-interleukin-1 agents.
- Evidence suggests these targeted therapies are promising for difficult-to-treat patients.
Conclusions:
- Accurate diagnosis is paramount for managing recurrent pericarditis.
- Anti-interleukin-1 agents represent a significant advancement in treating refractory recurrent pericarditis.
- Further research and clinical application of targeted therapies are warranted.
Related Concept Videos
Pericarditis III: Medical Management
Pericarditis II: Clinical Features and Diagnostic Tests
Pericarditis IV: Nursing Management
Pericarditis I: Introduction
Endocarditis III: Medical Management
Myocarditis IV: Nursing Management

